Skip to main content

Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease

The Original Article was published on 13 June 2013

Correction to: Alz Res Therapy 5, 32 (2013)

https://0-doi-org.brum.beds.ac.uk/10.1186/alzrt186

It has recently come to our attention that a paper we published in 2013 in Alzheimer’s Research & Therapy never included the tables (Tables 1, 2 and 3) and supplemental tables (Additional file 1) in the published manuscript [1]. This must have been an oversight at the proof or production stage.

Tables 1, 2 and 3 are shown below.

Table 1 Participants
Table 2 DAVID analysis of changes in proteins associated with platelet-specific secretion
Table 3 Overlap of AD platelet membrane protein changes with previously proposed mechanistic and diagnostic biomarkers

Reference

  1. Donovan LE, Dammer EB, Duong DM, et al. Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease. Alz Res Therapy. 2013;5:32. https://0-doi-org.brum.beds.ac.uk/10.1186/alzrt186.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Nicholas T. Seyfried or James J. Lah.

Supplementary Information

Additional file 1: Supplementary Table S1.

1009 proteins identified by unique peptides (top group members) identified in platelet membrane proteome from either a probable AD pool or a cognitive normal pool. Supplementary Table S2. 1957 total proteins (all potential group members) identified in platelet membrane proteome from either a probable AD pool or a cognitive normal pool. Supplementary Table S3. 144 potential marker proteins identified in platelet membrane proteome from a probable AD pool (FDR < 7%). Supplementary Table 4. 10 Classes incorporating 97 potentially novel AD biomarkers quantified in platelet membrane pools.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donovan, L.E., Dammer, E.B., Duong, D.M. et al. Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease. Alz Res Therapy 13, 102 (2021). https://0-doi-org.brum.beds.ac.uk/10.1186/s13195-021-00839-y

Download citation

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13195-021-00839-y